Diagnosis of Sickle Cell Crisis
Sickle cell crisis is diagnosed clinically based on acute severe pain in a patient with known sickle cell disease, supported by laboratory evidence of worsening hemolysis and exclusion of life-threatening complications. 1
Clinical Presentation
The diagnosis begins with recognizing the characteristic features of acute vaso-occlusive crisis:
- Acute severe pain in bones, joints, chest, or abdomen that is more severe than the patient's baseline chronic pain 1
- Fever may be present and requires immediate evaluation for infection, as infections are a leading cause of morbidity and mortality in sickle cell disease 1
- Respiratory symptoms including chest pain, dyspnea, or hypoxia should raise concern for acute chest syndrome 1
- Neurologic symptoms beyond transient mild headache require urgent stroke evaluation 1
Essential Laboratory Evaluation
A comprehensive laboratory panel is mandatory and should include complete blood count, markers of hemolysis, renal and liver function tests, and coagulation studies to assess crisis severity and detect organ damage. 2
Core Laboratory Tests
- Hemoglobin level must be compared to the patient's baseline (typically 6-9 g/dL in HbSS patients), as acute drops indicate hemolysis or sequestration 2
- Reticulocyte count assesses bone marrow response to hemolysis and helps differentiate hyperhemolytic crisis from aplastic crisis 2, 3
- White blood cell count may be elevated in acute crisis and can indicate infection or inflammation; higher WBC counts are associated with admission decisions 2, 4
- Bilirubin (total and direct) levels increase due to red cell breakdown 2
- Blood urea nitrogen and creatinine evaluate for acute kidney injury from vaso-occlusion 2
- Liver enzymes (AST, ALT, alkaline phosphatase) may be elevated with hepatobiliary involvement 2
- Coagulation studies (PT, PTT) assess for coagulopathy 2
Important Diagnostic Considerations
Baseline laboratory values must be known for comparison, as many patients have chronic abnormalities. 2 A hemoglobin of 7 g/dL may represent a significant acute drop for one patient but baseline for another. 2
The complete blood count and reticulocyte count alone do not determine admission decisions in uncomplicated vaso-occlusive crisis, though elevations in WBC count appear associated with admission. 4
Specialized Testing Based on Complications
For Suspected Acute Chest Syndrome
- Arterial blood gas to evaluate oxygenation and acid-base status 2
- Blood cultures if infection is suspected as a trigger 2
- Chest radiograph to identify new segmental infiltrates 1
For Suspected Stroke
- Review previous transcranial Doppler results (within 12 months for HbSS, 24 months for HbSC/HbSβ+ thalassemia) 2
- Neuroimaging for any acute neurologic symptom beyond transient mild headache 1
- CBC, reticulocyte count, blood type and crossmatch for potential exchange transfusion 1
For Suspected Priapism
- Corporal blood gas to differentiate ischemic from non-ischemic priapism 2
For Suspected Splenic Sequestration
- Serial hemoglobin measurements looking for drops >2 g/dL below baseline 1
- Physical examination for rapidly enlarging spleen 1
Critical Diagnostic Pitfalls to Avoid
Do not rely solely on hemoglobin levels to determine transfusion need—consider the patient's baseline hemoglobin and clinical status. 2
Screen all patients with hemoglobinopathies for recent transfusion at presentation, as hyperhemolysis syndrome can occur after transfusion and presents with precipitous hemoglobin drops despite ongoing reticulocytosis. 5 This life-threatening complication requires early steroid initiation and can be missed if transfusion history is not obtained. 5
In acute anemia with ongoing reticulocytosis and infection, consider hyperhemolytic crisis even without preceding transfusion, along with aplastic crisis, immune hemolytic anemia, and sequestration crises. 3
Obtain baseline oxygen saturation for comparison and monitor continuously until saturation is maintained at baseline in room air. 1
Blood cultures must be obtained if temperature reaches ≥38.0°C or signs of sepsis are present, with prompt antibiotic initiation. 1
Diagnostic Algorithm
- Confirm sickle cell disease diagnosis (should be known from newborn screening or previous hemoglobin electrophoresis) 6
- Assess pain severity and location using validated pain scales 1
- Measure vital signs including temperature, oxygen saturation, blood pressure, and respiratory rate 1
- Obtain comprehensive laboratory panel as outlined above 2
- Compare current values to patient's baseline (especially hemoglobin, which varies by genotype: HbSS typically 6-9 g/dL, HbSC higher) 7, 2
- Screen for life-threatening complications: acute chest syndrome (chest pain, respiratory symptoms, fever), stroke (neurologic symptoms), splenic sequestration (rapidly enlarging spleen, acute hemoglobin drop >2 g/dL), priapism (>4 hours duration) 1
- Obtain blood cultures if febrile and initiate antibiotics promptly 1
- Document recent transfusion history to assess hyperhemolysis risk 5